| |
|
|
| Name: |
Deep Track Capital LP |
| City: |
GREENWICH |
| State: |
CT |
| Zip: |
06830 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
74 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
INSM |
Insmed Inc |
1 |
- |
$24.92 |
$165,797,000 |
5,350,000 |
5.81% |
14,297,000 |
-650,000 |
3.53 |
Biotechnology |
|
|
SWTX |
Springworks Therapeutics, Inc. |
2 |
- |
$0.00 |
$148,324,000 |
4,063,676 |
5.2% |
66,330,000 |
517,241 |
5.845 |
N/A |
|
|
ITCI |
Intra Cellular Therapies Inc |
3 |
- |
$72.13 |
$143,240,000 |
2,000,000 |
5.02% |
7,806,000 |
-600,000 |
2.118 |
N/A |
|
|
GH |
Guardant Health, Inc. |
4 |
- |
$0.00 |
$135,250,000 |
5,000,000 |
4.74% |
15,208,000 |
950,000 |
5.002 |
N/A |
|
|
ARGX |
Argenx Se |
5 |
New |
$368.60 |
$114,129,000 |
300,000 |
4% |
114,129,000 |
300,000 |
0.638 |
N/A |
|
|
ALKS |
Alkermes Plc |
6 |
- |
$24.44 |
$110,960,000 |
4,000,000 |
3.89% |
4,522,000 |
200,000 |
2.433 |
Drug Delivery |
|
|
PLRX |
Pliant Therapeutics, Inc. |
7 |
- |
$0.00 |
$104,133,000 |
5,750,000 |
3.65% |
8,763,000 |
250,000 |
9.141 |
N/A |
|
|
DVAX |
Dynavax Technologies Corp |
8 |
- |
$11.17 |
$99,163,000 |
7,093,214 |
3.47% |
-637,000 |
336,258 |
5.264 |
Drug Manufacturers - ... |
|
|
AXSM |
Axsome Therapeutics, Inc. |
9 |
- |
$71.52 |
$79,590,000 |
1,000,000 |
2.79% |
-137,000 |
-140,745 |
2.678 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
10 |
- |
$12.70 |
$79,099,000 |
3,631,728 |
2.77% |
33,642,000 |
668,461 |
8.012 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
11 |
- |
$4.08 |
$76,438,000 |
11,869,297 |
2.68% |
41,488,000 |
-3,130,703 |
6.858 |
N/A |
|
|
PACB |
Pacific Biosciences Of Cali... |
12 |
- |
$1.38 |
$68,670,000 |
7,000,000 |
2.41% |
18,570,000 |
1,000,000 |
2.64 |
Biotechnology |
|
|
NTLA |
Intellia Therapeutics, Inc. |
13 |
- |
$20.02 |
$68,603,000 |
2,250,000 |
2.4% |
5,363,000 |
250,000 |
2.513 |
N/A |
|
|
TVTX |
Travere Therapeutics, Inc |
14 |
- |
$5.39 |
$66,256,000 |
7,370,000 |
2.32% |
368,000 |
0 |
8.411 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
15 |
- |
$45.86 |
$64,917,000 |
2,323,456 |
2.27% |
13,491,000 |
-90,917 |
6.248 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
16 |
- |
$0.00 |
$63,366,000 |
3,187,415 |
2.22% |
11,411,000 |
0 |
4.345 |
N/A |
|
|
IONS |
Ionis Pharmaceuticals Inc |
17 |
- |
$41.84 |
$63,190,000 |
1,249,068 |
2.21% |
-65,363,000 |
-1,585,001 |
0.894 |
Drug Manufacturers - ... |
|
|
BCYC |
Bicycle Therapeutics Ltd |
18 |
- |
$0.00 |
$63,108,000 |
3,490,506 |
2.21% |
-7,016,000 |
0 |
11.868 |
N/A |
|
|
GERN |
Geron Corporation |
19 |
- |
$3.56 |
$62,421,000 |
29,583,449 |
2.19% |
7,937,000 |
3,883,449 |
8.646 |
Drug Manufacturers - ... |
|
|
EDIT |
Editas Medicine, Inc. |
20 |
- |
$5.22 |
$55,442,000 |
5,473,086 |
1.94% |
47,000 |
-1,628,849 |
8.781 |
N/A |
|
|
AMAM |
Ambrx Biopharma Adr Represe... |
21 |
New |
$0.00 |
$52,836,000 |
3,710,412 |
1.85% |
52,836,000 |
3,710,412 |
4.123 |
N/A |
|
|
SRPT |
Sarepta Therapeutics Inc |
22 |
New |
$127.39 |
$48,215,000 |
500,000 |
1.69% |
48,215,000 |
500,000 |
0.594 |
Drug Manufacturers - ... |
|
|
TRML |
Tourmaline Bio |
23 |
New |
$0.00 |
$47,539,000 |
1,815,854 |
1.67% |
47,539,000 |
1,815,854 |
4.396 |
N/A |
|
|
HLVX |
Hillevax, Inc. |
24 |
- |
$12.02 |
$46,545,000 |
2,900,000 |
1.63% |
7,540,000 |
0 |
8.675 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
25 |
- |
$0.00 |
$46,281,000 |
2,284,372 |
1.62% |
10,916,000 |
-493,735 |
7.053 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
26 |
- |
$7.80 |
$44,580,000 |
1,793,966 |
1.56% |
19,650,000 |
293,966 |
4.968 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
27 |
- |
$18.87 |
$43,632,000 |
2,036,990 |
1.53% |
19,461,000 |
691,177 |
6.405 |
N/A |
|
|
IMVT |
Immunovant Inc |
28 |
- |
$0.00 |
$42,130,000 |
1,000,000 |
1.48% |
-65,283,000 |
-1,797,955 |
1.148 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
29 |
New |
$0.60 |
$42,023,000 |
1,952,760 |
1.47% |
42,023,000 |
1,952,760 |
3.192 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
30 |
New |
$0.00 |
$41,169,000 |
9,230,769 |
1.44% |
41,169,000 |
9,230,769 |
12.93 |
N/A |
|
|
ACLX |
Arcellx, Inc. |
31 |
New |
$0.00 |
$40,246,000 |
725,145 |
1.41% |
40,246,000 |
725,145 |
1.481 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
32 |
- |
$4.64 |
$39,589,000 |
6,100,000 |
1.39% |
9,409,000 |
100,000 |
10.934 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
33 |
- |
$0.00 |
$33,899,000 |
1,951,580 |
1.19% |
14,734,000 |
0 |
6.547 |
N/A |
|
|
ORTX |
Orchard Therapeutics Plc |
34 |
- |
$0.00 |
$33,585,000 |
2,041,670 |
1.18% |
17,803,000 |
0 |
11.096 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
35 |
New |
$0.00 |
$33,116,000 |
450,000 |
1.16% |
33,116,000 |
450,000 |
0.79 |
N/A |
|
|
ANIP |
ANI Pharmaceuticals Inc |
36 |
- |
$64.95 |
$33,084,000 |
600,000 |
1.16% |
9,860,000 |
200,000 |
2.937 |
Biotechnology |
|
|
NRIX |
Nurix Therapeutics, Inc. |
37 |
- |
$0.00 |
$30,938,000 |
2,997,830 |
1.08% |
7,375,000 |
0 |
6.373 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
38 |
- |
$0.00 |
$27,757,000 |
2,537,176 |
0.97% |
11,999,000 |
-212,824 |
3.634 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
39 |
- |
$0.00 |
$27,090,000 |
1,930,894 |
0.95% |
3,243,000 |
0 |
4.807 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
40 |
- |
$23.70 |
$26,600,000 |
2,000,000 |
0.93% |
5,063,000 |
-403,672 |
3.508 |
N/A |
|
|
AGEN |
Antigenics Inc |
41 |
- |
$0.44 |
$26,242,000 |
31,697,539 |
0.92% |
-9,576,000 |
0 |
14.496 |
Biotechnology |
|
|
CYTK |
Cytokinetics Inc |
42 |
New |
$64.80 |
$24,124,000 |
288,949 |
0.85% |
24,124,000 |
288,949 |
0.255 |
Biotechnology |
|
|
AGIO |
Agios Pharmaceuticals Inc |
43 |
- |
$31.67 |
$23,670,000 |
1,062,881 |
0.83% |
13,219,000 |
640,634 |
1.538 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
44 |
- |
$0.00 |
$21,847,000 |
2,992,731 |
0.77% |
-15,211,000 |
-75,000 |
8.144 |
N/A |
|
|
SRRK |
Scholar Rock Holding Corp |
45 |
- |
$13.96 |
$19,022,000 |
1,011,829 |
0.67% |
16,510,000 |
657,974 |
1.959 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
46 |
- |
$38.98 |
$12,228,000 |
300,000 |
0.43% |
-84,326,000 |
-1,615,000 |
0.784 |
N/A |
|
|
ZURA |
Zura Bio Ltd |
47 |
- |
$3.62 |
$11,782,000 |
2,523,000 |
0.41% |
-4,870,000 |
0 |
9.327 |
N/A |
|
|
NKTR |
Nektar Therapeutics |
48 |
- |
$1.32 |
$10,396,000 |
18,400,000 |
0.36% |
-563,000 |
0 |
10.256 |
Drug Delivery |
|
|
RLMD |
Relmada Therapeutics, Inc. |
49 |
- |
$3.70 |
$8,464,000 |
2,044,507 |
0.3% |
-49,000 |
-793,311 |
7.373 |
N/A |
|
|
ALLK |
Allakos Inc. |
50 |
- |
$1.01 |
$6,854,000 |
2,510,736 |
0.24% |
6,854,000 |
2,510,736 |
2.947 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
51 |
- |
$5.10 |
$6,454,000 |
828,485 |
0.23% |
3,181,000 |
0 |
1.474 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
52 |
New |
$24.66 |
$6,310,000 |
275,201 |
0.22% |
6,310,000 |
275,201 |
0.49 |
N/A |
|
|
JAZZ |
Jazz Pharmaceuticals Inc |
53 |
- |
$109.27 |
$5,938,000 |
48,280 |
0.21% |
-141,371,000 |
-1,089,765 |
0.079 |
Biotechnology |
|
|
VIGL |
Vigil Neuroscience, Inc. |
54 |
- |
$0.00 |
$5,391,000 |
1,594,931 |
0.19% |
-4,134,000 |
-172,200 |
5.642 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
55 |
New |
$0.00 |
$4,052,000 |
6,102,770 |
0.14% |
4,052,000 |
6,102,770 |
17.422 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
56 |
- |
$0.00 |
$2,897,000 |
499,400 |
0.1% |
-2,122,000 |
0 |
1.022 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
67 |
Closed |
$9.17 |
$0 |
0 |
0% |
-7,743,000 |
-1,037,873 |
0 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
73 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,430,000 |
-328,424 |
0 |
N/A |
|
|
HRTX |
Heron Therapeutics Inc |
60 |
Closed |
$2.55 |
$0 |
0 |
0% |
-2,149,000 |
-2,086,704 |
0 |
Synthetics |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
66 |
Closed |
$0.00 |
$0 |
0 |
0% |
-23,058,000 |
-1,259,335 |
0 |
N/A |
|
|
MORF |
Morphic Holding, Inc. |
72 |
Closed |
$27.98 |
$0 |
0 |
0% |
-10,783,000 |
-470,647 |
0 |
N/A |
|
|
TXG |
10x Genomics, Inc. |
59 |
Closed |
$0.00 |
$0 |
0 |
0% |
-7,536,000 |
-182,691 |
0 |
N/A |
|
|
ABOS |
Acumen Pharmaceuticals, Inc. |
65 |
Closed |
$0.00 |
$0 |
0 |
0% |
-10,429,000 |
-2,513,044 |
0 |
N/A |
|
|
NVAX |
Novavax Inc |
71 |
Closed |
$0.36 |
$0 |
0 |
0% |
-7,240,000 |
-1,000,000 |
0 |
Biotechnology |
|
|
IPSC |
Century Therapeutics, Inc. |
58 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,086,000 |
-543,008 |
0 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
64 |
Closed |
$4.24 |
$0 |
0 |
0% |
-5,607,000 |
-551,289 |
0 |
N/A |
|
|
NVCR |
Novocure Ltd |
70 |
Closed |
$12.23 |
$0 |
0 |
0% |
-40,375,000 |
-2,500,000 |
0 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
57 |
Closed |
$10.42 |
$0 |
0 |
0% |
-10,346,000 |
-7,720,688 |
0 |
N/A |
|
|
ETNB |
89bio, Inc. |
63 |
Closed |
$8.25 |
$0 |
0 |
0% |
-1,406,000 |
-91,078 |
0 |
N/A |
|
|
PNT |
Point Biopharma Global Ord Shs |
69 |
Closed |
$0.00 |
$0 |
0 |
0% |
-18,553,000 |
-2,781,565 |
0 |
N/A |
|
|
MRNA |
Moderna, Inc. |
62 |
Closed |
$0.00 |
$0 |
0 |
0% |
-20,658,000 |
-200,000 |
0 |
N/A |
|
|
BEAM |
Beam Therapeutics Inc. |
68 |
Closed |
$21.60 |
$0 |
0 |
0% |
-24,426,000 |
-1,015,641 |
0 |
N/A |
|
|
BNTX |
Biontech Se Adr |
74 |
Closed |
$0.00 |
$0 |
0 |
0% |
-21,728,000 |
-200,000 |
0 |
N/A |
|
|
NBIX |
Neurocrine Biosciences Inc |
61 |
Closed |
$137.76 |
$0 |
0 |
0% |
-33,750,000 |
-300,000 |
0 |
Biotechnology |
|
